Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items
2020-12-31